JPRN-UMIN000013929已完成未知
Clinical evaluation of tau-imaging PET tracer [18F]THK-5351 - Clinical evaluation of PET tracer [18F]THK-5351
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects with neuropsychiatric diseases other than Alzheimer's disease, subjects with severe cardiac abnormalities, and subjects with pacemaker or metal device in the body.
研究者
相似试验
已完成
不适用
Clinical evaluation of tau-imaging PET tracer [18F]THK-5117 in Alzheimer's disease patientsAlzheimer's disease and healthy volunteerJPRN-UMIN000010522Tohoku University School of Medicine17
已完成
不适用
Clinical evaluation of tau-imaging PET tracer [18F]THK-5351 in dementiamild cognitive impairment, Alzheimer's disease, corticobasal degeneration, progressive supranuclear palsy, frontotemporal dementia, dementia with Lewy bodies and Parkinson's disease and healthy volunteersJPRN-UMIN000043737Kagawa University210
Enrolling By Invitation
不适用
Study of Tau Imaging With the Use of [18F]MK-6240 TracerAlzheimer DiseaseNCT04104659Tammie L. S. Benzinger, MD, PhD200
已完成
不适用
Investigation for efficacy and safety of tau PET ligand [18F]PM-PBB3Alzheimer's disease (AD), mid cognitive impairment (MCI), progressive supranuclear pusy (PSP) and corticobasal syndrome (CBS).JPRN-UMIN000026490ational Institute of Radiological Sciences20
招募中
不适用
Investigation for efficacy and safety of tau PET ligand [18F]AM-PBB3Alzheimer's disease and mild cognitive impairmentJPRN-UMIN000029084ational Institute of Radiological Sciences20